Showing 1 - 6 results of 6 for search 'Walaa Ibraheem', query time: 0.03s
Refine Results
-
1
-
2
Design of novel coumarins as potent Mcl-1 inhibitors for cancer treatment guided by 3D-QSAR, molecular docking and molecular dynamics by Esraa Albasher Osman, Mohammed Abdalrahman Abdalla, Mohja Omer Abdelraheem, Mubarak Fadlalla Ali, Shima Albasher Osman, Yasmin Mohamed Tanir, Mohammed Abdelrahman, Walaa Ibraheem, Abdulrahim A. Alzain
Published 2021-01-01
Article -
3
Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies by Fatima A. Elbadwi, Elaf A. Khairy, Fatima O. Alsamani, Mariam A. Mahadi, Segood E. Abdalrahman, Zain Alsharf M. Ahmed, Inas Elsayed, Walaa Ibraheem, Abdulrahim A. Alzain, PhD
Published 2021-01-01
Article -
4
Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanopartic... by Abdalrahim M. Ali, Alaa A. Makki, Walaa Ibraheem, Mohammed Abdelrahman, Wadah Osman, Asmaa E. Sherif, Ahmed Ashour, Sabrin R. M. Ibrahim, Kholoud F. Ghazawi, Waad A. Samman, Abdulrahim A. Alzain
Published 2023-03-01
Article -
5
Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies by Nihal AbdElmoniem, Marwa H. Abdallah, Rua M. Mukhtar, Fatima Moutasim, Ahmed Rafie Ahmed, Alaa Edris, Walaa Ibraheem, Alaa A. Makki, Eman M. Elshamly, Rashid Elhag, Wadah Osman, Ramzi A. Mothana, Abdulrahim A. Alzain
Published 2023-02-01
Article -
6
Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies. by Tagyedeen H Shoaib, Walaa Ibraheem, Mohammed Abdelrahman, Wadah Osman, Asmaa E Sherif, Ahmed Ashour, Sabrin R M Ibrahim, Kholoud F Ghazawi, Samar F Miski, Sara A Almadani, Duaa Fahad ALsiyud, Gamal A Mohamed, Abdulrahim A Alzain
Published 2023-01-01
Article